Early critic of diabetes drug says don't panic

(Reuters) - Dr. John Buse, chief of endocrinology at the University of North Carolina at Chapel Hill and incoming president of the American Diabetes Association, was one of the first experts to query the safety of GlaxoSmithKline's blockbuster drug.




He raised questions about the drug's heart safety in 2000.


Read more at Reuters.com Government Filings News